AstraZeneca said it has decided to ask the U.S. Food and Drug Administration for full regulatory approval of the vaccine, rather than the fast-track emergency use authorization originally anticipated.
AstraZeneca said it has decided to ask the U.S. Food and Drug Administration for full regulatory approval of the vaccine, rather than the fast-track emergency use authorization originally anticipated.
Copyright © 2024 | WordPress Theme by MH Themes